Correlation Between Viking Therapeutics and Galectin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Galectin Therapeutics, you can compare the effects of market volatilities on Viking Therapeutics and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Galectin Therapeutics.
Diversification Opportunities for Viking Therapeutics and Galectin Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Galectin is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Galectin Therapeutics go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Galectin Therapeutics
Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the Galectin Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Viking Therapeutics is 1.39 times less risky than Galectin Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Galectin Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 213.00 in Galectin Therapeutics on November 3, 2024 and sell it today you would lose (88.00) from holding Galectin Therapeutics or give up 41.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Galectin Therapeutics
Performance |
| Timeline |
| Viking Therapeutics |
| Galectin Therapeutics |
Viking Therapeutics and Galectin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Galectin Therapeutics
The main advantage of trading using opposite Viking Therapeutics and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Galectin Therapeutics vs. Madrigal Pharmaceuticals | Galectin Therapeutics vs. Viking Therapeutics | Galectin Therapeutics vs. Sarepta Therapeutics | Galectin Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |